BLAST CELL COUNT INCREASED side effect
What is BLAST CELL COUNT INCREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
BLAST CELL COUNT INCREASED and Recently Reported Side Effects
BLAST CELL COUNT INCREASED and 15 most Active Side Effect polls
BLAST CELL COUNT INCREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with BLAST CELL COUNT INCREASED
BETASERON CLOFARABINE CLOZAPINE CYCLOSPORINE CYTARABINE DASATINIB GLEEVEC MYLOTARG NEORAL NOVANTRONE REVLIMID STEMGEN THALOMIDDasatinib Side Effects Report #5657195-1
Consumer or non-health professional from SWEDEN reported DASATINIB problem on Mar 05, 2008. Male patient, 59 years of age, was diagnosed with chronic myeloid leukaemia and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, dyspnoea, pleural effusion, . DASATINIB dosage: 140MG 08JUN TO 08JUL-05; 200MG 08JUL05 TO 17JAN06, 27JAN TO 15FEB06; 140MG 18FEB TO 28FEB06. During the same period patient was treated with DARBEPOETIN ALFA, TRAMADOL, CYANOCOBALAMIN, ALLOPURINOL, ACETAMINOPHEN, LOPERAMIDE, FLUCONAZOLE, FUROSEMIDE. Patient was hospitalized. Patient died.
Dasatinib Side Effects Report #5661837-4
DASATINIB problem was reported by a Consumer or non-health professional from SWEDEN on Mar 05, 2008. Male patient, 59 years of age, was diagnosed with chronic myeloid leukaemia and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, dyspnoea, malignant neoplasm progression, pleural effusion, . DASATINIB dosage: 140MG 08JUN TO 08JUL-05; 200MG 08JUL05 TO 17JAN06, 27JAN TO 15FEB06; 140MG 18FEB TO 28FEB06. During the same period patient was treated with DARBEPOETIN ALFA, TRAMADOL, CYANOCOBALAMIN, ALLOPURINOL, ACETAMINOPHEN, LOPERAMIDE, FLUCONAZOLE, FUROSEMIDE. Patient was hospitalized. Patient died on 05/26/2006.
Cyclosporine Side Effects Report #5680201-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Mar 19, 2008. Female patient, child 10 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, graft versus host disease, graft versus host disease in lung, obliterative bronchiolitis, . CYCLOSPORINE dosage: 1MG/KG/DAY. During the same period patient was treated with METHOTREXATE, TACROLIMUS, PREDNISOLONE. Patient died.
Stemgen Side Effects Report #5682417-0
STEMGEN problem was reported by a Physician from FRANCE on Mar 12, 2008. Male patient, weighting 168.7 lb, was diagnosed with peripheral blood stem cell apheresis, blood stem cell harvest and was treated with STEMGEN. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, . STEMGEN dosage: unknown. During the same period patient was treated with NEUPOGEN, VENTOLIN, ZYRTEC, RANITIDINE, VALACYCLOVIR, PENTACARINAT, ARACYTINE. Patient was hospitalized. Patient recovered.
Gleevec Side Effects Report #5474457-1
Physician from CANADA reported GLEEVEC problem on Sept 25, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, pulmonary mass, . GLEEVEC dosage: 600 MG, QD. Patient was hospitalized. Patient recovered.
Novantrone Side Effects Report #5420196-2
NOVANTRONE problem was reported by a Consumer or non-health professional from FRANCE on Aug 06, 2007. Male patient, 17 years of age, was diagnosed with acute myeloid leukaemia, bronchopulmonary aspergillosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, bronchopulmonary aspergillosis, cardio-respiratory arrest, cerebellar syndrome, coma, confusional state, convulsion, decerebration, eye movement disorder, . NOVANTRONE dosage: 20 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, AMIKLIN, AMISIDINE, CYTARABINE. Patient was hospitalized. Patient died on 06/10/2007.
Clozapine Side Effects Report #5746654-9
Physician from NEW ZEALAND reported CLOZAPINE problem on May 09, 2008. Male patient, 53 years of age, was diagnosed with schizophrenia, diffuse large b-cell lymphoma and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, diffuse large b-cell lymphoma, haematocrit decreased, haemoglobin decreased, hypochromasia, lymph node cancer metastatic, lymphocyte count decreased, metamyelocyte count increased, monocyte count increased, . CLOZAPINE dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5360119-8
CYTARABINE problem was reported by a Health Professional from JAPAN on June 13, 2007. Female patient, 61 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, cerebral haemorrhage, . CYTARABINE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
Cytarabine Side Effects Report #5337958-2
Health Professional from JAPAN reported CYTARABINE problem on May 23, 2007. Female patient, 61 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, cerebral haemorrhage, . CYTARABINE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
Mylotarg Side Effects Report #5255549-9
MYLOTARG problem was reported by a Physician from JAPAN on Feb 22, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, neutrophil count decreased, performance status decreased, pneumonia, pyrexia, white blood cell count increased, . MYLOTARG dosage: unknown. During the same period patient was treated with GASTER, ZOLPIDEM TARTRATE, BAKTAR, MUCOSTA, ETODOLAC, PRORENAL. Patient recovered.
Mylotarg Side Effects Report #5259103-4
Physician from JAPAN reported MYLOTARG problem on Mar 06, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, neutrophil count decreased, performance status decreased, pneumonia, pyrexia, white blood cell count increased, . MYLOTARG dosage: unknown. During the same period patient was treated with GASTER, ZOLPIDEM TARTRATE, BAKTAR, MUCOSTA, ETODOLAC, PRORENAL. Patient recovered.
Revlimid Side Effects Report #5270611-2
REVLIMID problem was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Male patient, 43 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, organ failure, sepsis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FOSAMAX, CALCIUM, AUGMENTIN, PREDNISONE, FOLIC ACID, PENTAMIDINE, ACYCLOVIR, ZITHROMAX. Patient died on 10/14/2006.
Neoral Side Effects Report #5662694-2
Consumer or non-health professional from JAPAN reported NEORAL problem on Mar 05, 2008. Male patient, 55 years of age, was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, blast cell count increased, cholecystitis infective, cytogenetic abnormality, cytomegalovirus enterocolitis, engraftment syndrome, herpes zoster, leukaemia, marrow hyperplasia, . NEORAL dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE, FLUDARABINE, CYCLOPHOSPHAMIDE, IRRADIATION. Patient was hospitalized. Patient died.
Gleevec Side Effects Report #5573294-7
GLEEVEC problem was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, blood creatinine increased, bone pain, brain oedema, dyslalia, eosinophil count increased, haematocrit decreased, haemoglobin decreased, . GLEEVEC dosage: 100 MG, QD. Patient was hospitalized and became disabled. Patient died on 09/21/2005.
Gleevec Side Effects Report #5575997-7
Physician from CANADA reported GLEEVEC problem on Dec 21, 2007. Male patient, 68 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, myelocyte count increased, platelet count decreased, . GLEEVEC dosage: 600 MG, QD. Patient was hospitalized. Patient recovered.
Gleevec Side Effects Report #5501780-4
GLEEVEC problem was reported by a Physician from JAPAN on Oct 26, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, blood creatinine increased, bone pain, brain oedema, dyslalia, eosinophil count increased, haematocrit decreased, haemoglobin decreased, . GLEEVEC dosage: 100 MG, QD. Patient was hospitalized and became disabled. Patient died on 09/21/2005.
Gleevec Side Effects Report #5502556-4
Physician from JAPAN reported GLEEVEC problem on Oct 26, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, blood creatinine increased, bone pain, brain oedema, dyslalia, eosinophil count increased, haematocrit decreased, haemoglobin decreased, . GLEEVEC dosage: 100 MG, QD. Patient was hospitalized and became disabled. Patient died on 09/21/2005.
Clofarabine Side Effects Report #5407908-9
CLOFARABINE problem was reported by a Physician from UNITED STATES on Apr 24, 2007. Male patient, 17 years of age, weighting 88.18 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, blast cell count increased, blast cells present, blood culture positive, blood glucose increased, blood phosphorus decreased, blood pressure decreased, bone marrow failure, caecitis, . CLOFARABINE dosage: 42 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, BACTRIM, POTASSIUM CHLORIDE, VALTREX, COLACE, MYLANTA, OXYCONTIN. Patient was hospitalized. Patient recovered.
Betaseron Side Effects Report #5357623-5
Physician from UNITED STATES reported BETASERON problem on May 31, 2007. Female patient, 51 years of age, weighting 192.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, chronic myeloid leukaemia, eosinophil count increased, haematocrit decreased, hypersensitivity, injection site pain, monocyte count increased, multiple sclerosis, . BETASERON dosage: unknown. During the same period patient was treated with BACLOFEN, WELLBUTRIN, ATIVAN, GLEEVEC. Patient recovered.
Mylotarg Side Effects Report #5324992-1
MYLOTARG problem was reported by a Physician from JAPAN on May 07, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, condition aggravated, haematuria, hypokalaemia, platelet count decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with ITRACONAZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient recovered.
Thalomid Side Effects Report #5298678-6
Physician from UNITED STATES reported THALOMID problem on Apr 03, 2007. Male patient, 74 years of age, was diagnosed with myelofibrosis and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blast cell count increased, diarrhoea haemorrhagic, disease progression, haematocrit decreased, haemoglobin decreased, myelofibrosis, pneumonia, pyrexia, . THALOMID dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with DECADRON, ATENOLOL, HYDROXYZINE, LASIX, POTASSIUM CHLORIDE, PROLOSEC. Patient was hospitalized. Patient died on 03/17/2007.
Mylotarg Side Effects Report #5404331-8
MYLOTARG problem was reported by a Physician from JAPAN on July 26, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, . MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, DIFLUCAN, POLYMYXIN B SULPHATE, ZANTAC, MUCOSTA. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5767973-6
Health Professional from GERMANY reported REVLIMID problem on June 02, 2008. Male patient, 69 years of age, weighting 238.1 lb, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, back pain, blast cell count increased, bone pain, bronchitis, diverticulitis, gamma-glutamyltransferase increased, hypokalaemia, intervertebral discitis, . REVLIMID dosage: 25 MG, DAILY, ORAL : 15 MG, EVERY OTHER DAY, ORAL. During the same period patient was treated with ANTICOAGULANT, RAMIPRIL, DIGOXIN, TORASEMID, CEFUROXIME. Patient was hospitalized. Patient died on 03/25/2008.
Cyclosporine Side Effects Report #5694469-2
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2008. Female patient, child 10 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute myeloid leukaemia, blast cell count increased, cough, diarrhoea, dyspnoea, graft versus host disease, graft versus host disease in lung, infection, . CYCLOSPORINE dosage: 1MG/KG/DAY. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, DONOR LEUKOCYTE INFUSIONS. Patient died.
Mylotarg Side Effects Report #5353493-X
Physician from JAPAN reported MYLOTARG problem on May 31, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, emphysema and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, . MYLOTARG dosage: unknown. During the same period patient was treated with MUCOSTA, BAKTAR, POLYMYXIN B SULPHATE, CLARITHROMYCIN, ZANTAC, DIFLUCAN. Patient was hospitalized. Patient recovered.